What is Oraceutical?
Oraceutical operates at the intersection of biotechnology and consumer health, serving as a critical partner for entities requiring sophisticated oral care research and development. The company distinguishes itself by offering a comprehensive suite of services, ranging from high-viscosity product filling and specialty manufacturing to rigorous analytical and stability testing. By providing essential regulatory guidance alongside its technical expertise, Oraceutical acts as a foundational pillar for dental professionals and consumer brands aiming to bring innovative, science-backed products to market. Their ability to navigate the complex regulatory landscapes of both human and veterinary medicine provides a distinct competitive advantage in a fragmented industry.
How much funding has Oraceutical raised?
Oraceutical has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Oraceutical
PPP
Public-Private Partnership
What's next for Oraceutical?
With the successful closure of this major strategic investment, Oraceutical is well-positioned to scale its manufacturing infrastructure and expand its licensing portfolio. The company is expected to leverage this capital to deepen its research capabilities, potentially accelerating the development of next-generation oral care formulations. As the firm transitions into this late-stage growth phase, the focus will likely shift toward optimizing operational efficiencies and broadening its footprint in the companion-animal health market, a sector currently experiencing high demand for professional-grade dental solutions. By maintaining its commitment to high-quality analytical standards, Oraceutical is poised to remain a dominant force in the oral care technology ecosystem.
See full Oraceutical company page
